Influenza B Antigen

100% Secure

Native Influenza B Antigen

Product Type
Antigen
Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
PIP012 E 1 ml
This product is a native influenza B antigen. Influenza is an acute infection of the respiratory tract caused by the Influenza virus, of which there are several different types.

Influenza B is only known to infect humans and seals. Influenza infection in humans causes chills, fever, pharyngitis, muscle pain, headaches, coughing and weakness. The virus is transmitted through the air by coughs or sneezes or through saliva, nasal secretions, faeces and blood. Infection may occur through direct contact with infected bodily fluid or contaminated surfaces. Influenza B viruses mutate slower than Influenza A, but fast enough that lasting immunity is not possible. The slower mutation rate and limited host range makes Influenza B less like to cause pandemics than Influenza A.

Product Details

Target Species
Viral
Product Form
Inactivated Influenza B antigen - liquid.
Preparation
Clarified and concentrated cell culture supernatant.

The antigen preparation is inactivated by gamma radiation.
Source
Influenza B, strain Hong Kong 5/72, cultured in MDCK cells.
Buffer Solution
Eagle's Minimum Essential Medium
Preservative Stabilisers
None present
Activity
This product has been rendered inactive by gamma radiation. However this material should still be handled as infectious and should be disposed of appropriately.
Approx. Protein Concentrations
Total protein concentration 1.75 mg/ml

Storage Information

Storage
Store at -70oC.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted.
Avoid repeated freezing and thawing as this may denature the protein.
Shelf Life
18 months from date of despatch.

More Information

Regulatory
For research purposes only

Applications of Influenza B Antigen

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
ELISA
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Instructions For Use
The preparation might be slightly cloudy or contain minor precipitate upon thawing. Do not sonicate and do not clarify prior to dilution at least 10-fold with working buffer.